Trial site
Nanjing Jiangning Hospital
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Obesity4 trials
- Heart failure3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Type 2 diabetes2 trials
- Asthma1 trial
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- COPD1 trial
- Liver cirrhosis1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Phase 23 trials
- Status
- Completed6 trials
- Recruiting4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim4 trials
- Beijing QL Biopharmaceutical Co.,Ltd2 trials
- Shenzhen HighTide Biopharmaceutical Ltd.2 trials
- Bayer1 trial
- Cascade Pharmaceuticals, Inc1 trial
- and 3 more
Running trials
Active, not recruiting
A Study of CS060380 Tablets in Patients With MASH and Obesity
Recruiting
Active, not recruiting
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Asthma1 recruiting
- COPD1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
A Study of ZT002 Injection With Subjects With Overweight or Obesity
Completed
Completed
Completed
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Completed
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026